QuidelOrtho News and Activities
Presence
QuidelOrtho develops and supplies diagnostic testing and transfusion medicine products. Its products support hospitals, laboratories, blood banks, and healthcare providers with clinical testing and patient care.
QuidelOrtho products and services overview:
- Diagnostic tests
- Immunoassay systems
- Molecular diagnostics
- Blood screening
- Transfusion medicine
- Clinical chemistry
Revenue: ~$3 billion
Employees: 6,600
Headquarters: San Diego, United States (USA)
QuidelOrtho is one of the...
QuidelOrtho is a company listed under the stock ticker QDEL (US).
QuidelOrtho has a direct presence in 4 countries.QuidelOrtho has 3 subsidiaries including LEX Diagnostics, QuidelOrtho APAC and QuidelOrtho EMEA.
They are in:
Acquisition, funding and merger involving QuidelOrtho.
- QuidelOrtho has acquired LEX Diagnostics (posted on April 22 2026).
- QuidelOrtho has acquired LEX Diagnostics (posted on April 20 2026).
Executives
View the org chart displaying its 49 main executives
Most searched biographies at QuidelOrtho
- Brian Blaser, Director, President and Chief Executive Officer
- Joseph Wilkins, Director
- Kenneth Widder, Director
Popular executive movements at QuidelOrtho
- Nathaniel Sisitsky has joined the company as Chief Legal Officer (posted on March 24 2026).
Create your alert
to follow the executive moves at QuidelOrtho.
Medical Equipment
QuidelOrtho has 1,235 competitors including Thermo Fisher Scientific (United States (USA)), Medtronic (Ireland) and Philips (Netherlands).
Popular M&A news in Medical Equipment
- Niowave has just announced a $70 Million fundraising (posted on June 2 2026).
- The new name of Edap Tms is FocalTherics. (posted on June 1 2026).
- FocalTherics is now listed under ticker FOCL. (posted on May 31 2026).
Popular contacts in Medical Equipment
News
Press releases by QuidelOrtho
- QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies | QuidelOrthoBack ButtonSearch IconFilter Icon
- QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences | QuidelOrtho
- When Blood Compatibility Becomes a Pregnancy Risk | QuidelOrtho
- QuidelOrtho Reports First Quarter 2026 Financial Results | QuidelOrthoBack ButtonSearch IconFilter Icon
- Understanding and Addressing Syphilis Trends - and What's Being Missed | QuidelOrthoBack ButtonSearch IconFilter Icon
- QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics | QuidelOrthoBack ButtonSearch IconFilter Icon
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance | QuidelOrthoBack ButtonSearch IconFilter Icon
- Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer | QuidelOrthoBack ButtonSearch IconFilter Icon
- Faster Cardiac Answers with High‑Sensitivity Troponin | QuidelOrthoBack ButtonSearch IconFilter Icon
- QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference | QuidelOrthoBack ButtonSearch IconFilter Icon
- View more press releases Close
Social media about QuidelOrtho
- QuidelOrtho on Wikipedia, Google News & Yahoo Finance
- QuidelOrtho on LinkedIn, X (Twitter) & YouTube
